Lonafarnib, Trastuzumab, and Paclitaxel in Treating Patients With HER2/Neu-Overexpressing Stage IIIB, Stage IIIC, or Stage IV Breast Cancer

This study is currently recruiting participants.

Study NCT00068757 Information provided by National Cancer Institute (NCI)

First Received: September 10, 2003 Last Updated: June 16, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	June 2008 (Final data collection date for primary outcome measure)